SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share (SVA)
CUSIP: P8696W104
Q4 2017 13F Holders as of 31 Dec 2017
- Type / Class
- Equity / Common Shares, par value US$0.001 per share
- Shares outstanding
- 71,872,133
- Total 13F shares
- 7,195,807
- Share change
- -568,647
- Total reported value
- $56,704,456
- Price per share
- $7.88
- Number of holders
- 30
- Value change
- -$4,237,018
- Number of buys
- 11
- Number of sells
- 15
Quarterly Holders Quick Answers
What is CUSIP P8696W104?
CUSIP P8696W104 identifies SVA - SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP P8696W104:
Top shareholders of SVA - SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| SAIF Advisors Ltd |
13F
|
Company |
15%
|
10,780,820
|
$76,005,000 | — | 30 Sep 2017 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
3.7%
|
2,667,500
|
$18,806,000 | — | 30 Sep 2017 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
3%
|
2,170,200
|
$15,300,000 | — | 30 Sep 2017 | |
| GLG Partners LP |
13F
|
Company |
1.1%
|
758,859
|
$5,342,000 | — | 30 Sep 2017 | |
| MORGAN STANLEY |
13F
|
Company |
0.9%
|
649,848
|
$4,581,000 | — | 30 Sep 2017 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.28%
|
204,214
|
$1,439,000 | — | 30 Sep 2017 | |
| Freedom Investment Management, Inc. |
13F
|
Company |
0.21%
|
149,539
|
$1,054,000 | — | 30 Sep 2017 | |
| WOLVERINE ASSET MANAGEMENT LLC |
13F
|
Company |
0.14%
|
99,212
|
$699,000 | — | 30 Sep 2017 | |
| STATE STREET CORP |
13F
|
Company |
0.11%
|
78,336
|
$552,000 | — | 30 Sep 2017 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.1%
|
69,098
|
$486,000 | — | 30 Sep 2017 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.09%
|
62,000
|
$436,000 | — | 30 Sep 2017 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.08%
|
58,083
|
$409,000 | — | 30 Sep 2017 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.08%
|
54,138
|
$381,000 | — | 30 Sep 2017 | |
| Walleye Trading LLC |
13F
|
Company |
0.07%
|
49,065
|
$346,000 | — | 30 Sep 2017 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.05%
|
34,193
|
$241,000 | — | 30 Sep 2017 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.04%
|
31,261
|
$220,000 | — | 30 Sep 2017 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.04%
|
30,400
|
$214,000 | — | 30 Sep 2017 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.04%
|
27,717
|
$195,000 | — | 30 Sep 2017 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
0.03%
|
24,739
|
$174,000 | — | 30 Sep 2017 | |
| SG Americas Securities, LLC |
13F
|
Company |
0.03%
|
23,141
|
$163,000 | — | 30 Sep 2017 | |
| GUGGENHEIM CAPITAL LLC |
13F
|
Company |
0.03%
|
18,382
|
$129,000 | — | 30 Sep 2017 | |
| Spark Investment Management LLC |
13F
|
Company |
0.02%
|
17,800
|
$125,000 | — | 30 Sep 2017 | |
| DLD Asset Management, LP |
13F
|
Company |
0.02%
|
15,000
|
$106,000 | — | 30 Sep 2017 | |
| Verity Asset Management, Inc. |
13F
|
Company |
0.02%
|
13,542
|
$98,000 | — | 30 Sep 2017 | |
| PRELUDE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.02%
|
13,200
|
$93,000 | — | 30 Sep 2017 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.02%
|
12,259
|
$86,000 | — | 30 Sep 2017 | |
| Virtu Financial LLC |
13F
|
Company |
0.01%
|
10,119
|
$71,000 | — | 30 Sep 2017 | |
| UBS Group AG |
13F
|
Company |
0%
|
2,048
|
$14,000 | — | 30 Sep 2017 | |
| IFP Advisors, Inc |
13F
|
Company |
0%
|
2,000
|
$14,000 | — | 30 Sep 2017 | |
| SIMPLEX TRADING, LLC |
13F
|
Company |
0%
|
1,771
|
$12,000 | — | 30 Sep 2017 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
1,250
|
$9,000 | — | 30 Sep 2017 | |
| CWM, LLC |
13F
|
Company |
0%
|
500
|
$4,000 | — | 30 Sep 2017 | |
| LADENBURG THALMANN FINANCIAL SERVICES INC. |
13F
|
Company |
0%
|
300
|
$2,000 | — | 30 Sep 2017 | |
| Geneos Wealth Management Inc. |
13F
|
Company |
0%
|
150
|
$1,000 | — | 30 Sep 2017 |
Institutional Holders of SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share (SVA) as of Q4 2017
As of 31 Dec 2017,
SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share (SVA) was held by
30 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,195,807 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, RENAISSANCE TECHNOLOGIES LLC, Neumann Advisory Hong Kong Ltd, GLG Partners LP, DEUTSCHE BANK AG\, Eqis Capital Management, Inc., STATE STREET CORP, WELLINGTON MANAGEMENT GROUP LLP, Spark Investment Management LLC, and CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM.
This page lists
30
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2017 vs Q3 2017 Across Filers
Q3 2017 holders
34
Q4 2017 holders
30
Holder diff
-4
| Investor | Q3 2017 Shares | Q4 2017 Shares | Share Diff | Share Chg % | Q3 2017 Value $ | Q4 2017 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.